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Design considerations for the synthesis of
polymer coated iron oxide nanoparticles for stem
cell labelling and tracking using MRI
Michael Barrow,a Arthur Taylor,b Patricia Murray,b Matthew J. Rosseinskya and
Dave J. Adams*a
Iron oxide nanoparticles (IONPs, sometimes called superparamagnetic iron oxide nanoparticles or
SPIONs) have already shown promising results for in vivo cell tracking using magnetic resonance
imaging (MRI). To fully exploit the potential of these materials as contrast agents, there is still a need for
a greater understanding of how they react to physiological conditions. A key aspect is the specific
nature of the surface coating, which can aﬀect important properties of the IONPs such as colloidal
stability, toxicity, magnetism and labelling eﬃciency. Polymers are widely used as coatings for IONPs as
they can increase colloidal stability in hydrophilic conditions, as well as protect the iron oxide core from
degradation. In this tutorial review, we will examine the design and synthesis approaches currently being
employed to produce polymer coated IONPs as cell tracking agents, and what considerations must be
made. We will also give some perspective on the challenges and limitations that remain for polymer
coated IONPs as MRI contrast agents for stem cell tracking.
Key learning points
(1) How and why IONPs are used for tracking stem cells
(2) How to synthesise hydrophilic polymer coated IONPs and polymer grafting methods
(3) Potential safety problems regarding IONPs
(4) Strategies to increase uptake of polymer coated IONPs into stem cells
(5) Limitations of stem cell tracking using polymer coated IONPs and MRI
1 Introduction
Stem cells are of great interest for the treatment of a wide range
of diseases and disorders owing to their potential ability to
regenerate or stimulate the regeneration of diseased host tissue.
An important aspect of using stem cells in regenerative therapies
is the ability of scientists and clinicians to image them once they
are administered to an organism, allowing the tracking of their
localisation within the body. This is critical in order to assess the
engraftment and migration of the cells, and can give important
information in respect to the therapeutic eﬃcacy of the cells, as
well as the safety of the therapy.1 Currently, pre-clinical imaging
technologies such as optical, photoacoustic, nuclear and mag-
netic resonance imaging (MRI) are employed for this purpose.2
Stem cell imaging using these techniques usually involves
the labelling of the cells with a probe or contrast agent that
allows them to be distinguished from the host cells, as shown
in Fig. 1.
Clinically, MRI is often preferred as it does not suﬀer from
issues such as penetration depth or spatial resolution limita-
tions. An MRI scanner allows visualisation of living tissue by
positioning a patient or tissue sample in a position containing
a very strong external magnetic field of typically 1.5 T or 3 T in
the clinic and up to 21 T pre-clinically. A radio-frequency pulse
is applied through a coil, which causes a tip in the net magneti-
sation of protons to a plane that is adjacent to the main
magnetic field.
The time taken for the recovery of the magnetisation vector
to return to its equilibrium state within the magnetic field is
known as relaxation time, and is measured in two diﬀerent ways.
The T1 relaxation time corresponds to the rate at which the
longitudinal component of the magnetisation vector returns to
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its equilibrium state and T2 relaxation time corresponds to the
decay of the transverse component (axial spin) of the magneti-
sation vector towards equilibrium. During relaxation, radio
waves emitted by protons are detected by receiver coils, which
can be used to create MR images.3
External agents can be used as a means to enhance the
contrast of MR images by introducing a material that can alter
the relaxation times of surrounding water protons (1H MRI
contrast agents), or to discriminate between water and other
materials in the case of fluorine MRI contrast agents. Contrast
agents for 1H MRI usually contain paramagnetic or super-
paramagnetic materials, which are materials that only become
magnetised under the influence of an external magnetic field.
Such agents are generally split into T1 and T2 categories: most
commonly, T1 contrast agents contain a paramagnetic metal
lanthanide complex that alters the longitudinal (T1) relaxation
times of surrounding water protons whilst T2 agents, contain-
ing a superparamagnetic iron oxide core less than 20 nm in
diameter,4 alter the transverse (T2) relaxation times of water
protons. The eﬃciency of contrast agents in decreasing the
relaxation time of surrounding protons is normally expressed
in terms of their relaxivity, defined as r1 and r2 for longitudinal
and transverse relaxivity, respectively. Both types of agents can
be introduced into stem cells in vitro thus enabling a contrast
distinct to that of the host tissue to be obtained once they are
administered to a model organism. IONPs (T2 agents) are now
more widely investigated due to their established synthetic
procedures, high sensitivity, biocompatibility, and increased
paramagnetism per mole of metal compared to gadolinium
based T1 contrast agents.
4 Fig. 2 displays an example of in vivo
tracking of stem cells using such systems. Stem cells were
labelled with IONPs and then injected intra-aortally via the left
carotid artery into animals with an induced acute kidney injury.
Accumulation of the cells in the renal cortex is observed via the
loss of signal (negative contrast) 1–2 hours after injection of the
cells (Fig. 2b and e vs. baseline control Fig. 2a and d). This
effect was seen up to 14 days after administration (Fig. 2c).5
There are currently no iron oxide based contrast agents
clinically approved for stem cell labelling. The two formally
approved products used for labelling, subsequently removed from
the market in 2009, were initially developed as liver specific
contrast agents and required the use of a transfection agent to
eﬃciently label stem cells.6 There is now considerable interest
in developing novel IONPs for use in stem cell tracking. The
ultimate goal is to take tailor-made IONPs from synthesis
through to clinical and commercial application. When designing
IONPs to be used as MRI contrast agents, one must take into
consideration issues related to their interactions with living
systems. Long-term stability in hydrophilic conditions is an
important requirement. This is normally split into two categories:
colloidal stability of the particles and the chemical stability of the
iron oxide core. Use of IONPs for any cell labelling and tracking
application requires a hydrophilic coating to make the particles
stable in aqueous solutions. Stability in aqueous solution is
necessary for sample storage and transfer into cell culture
medium for labelling; if any sedimentation occurs, it would
present negative implications for downstream applications.
Colloidal stability in serum is not absolutely essential, although
it is desirable if one wants to understand interactions of IONPs
with stem cells based on surface properties rather than induced
by gravitational forces (sedimentation). Once internalised inside
stem cells, the chemical stability of the core of IONPs becomes
relevant as they normally become localised within endosomes
and lysosomes, where the slightly acidic pH (B4.5) can ‘‘erode’’
particles resulting in a loss of MRI signal. The particles must
Fig. 1 Stem cell tracking using IONPs and MRI: stem cells are first labelled
with IONPs in vitro and then administered into a host that can be imaged
non-invasively using a MR scanner. The region containing the adminis-
tered cells (e.g. right kidney) is detectable due to an increase in negative
contrast caused by changes in the relaxation times of surrounding protons
as caused by the presence of IONPs.
Fig. 2 MR images showing accumulation of rat mesenchymal stem cells
labelled with IONPs in the cortex (outer portion) of a rat’s kidneys (axial a–c,
coronal d and e, kidneys are indicated with arrowheads). T2* weighted
gradient echo images. Images were acquired 3 days before injection (a & d),
1–2 hours after injection (b & e) and 14 days after injection (c) with a loss of
signal in the renal cortex after cell administration. Adapted with permission
from ref. 5. Copyright r 2007, John Wiley and Sons. Original image has
been annotated to add arrowheads.
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retain the necessary magnetic properties, altering the T2 relaxa-
tion time of the surrounding water protons, for the period of
time that is required not only to assess the delivery of the cells
but also the eﬃcacy and safety of the therapy. This can range
from several days to several months depending on the experi-
mental conditions and model organism. It is important to note
that MRI alone is not always eﬃcient enough for tracking stem
cells in vivo as, in some cases, the contrast agent might be trans-
ferred to the host cells after cell death, giving false positives.2
To work around this problem, many researchers are now adopt-
ing multi-modal imaging approaches, combining MRI with other
imaging technologies.7
Chemical coatings that result in high cell labelling eﬃciency
with no toxicological eﬀect can be of great advantage to cellular
imaging, as these allow greater control of the labelling process
without the need of transfection agents that can add extra cost,
have possible toxicological implications and require their own
clinical approval. Polymers are often preferred to small mole-
cules as coatings as they can provide both colloidal stability and
suﬃcient protection of the iron oxide core at physiological pH.
Through various synthetic procedures, the properties of the
IONPs can be tailored to maximise all of the properties men-
tioned above. In this tutorial review, we will discuss the design,
polymer selection and synthesis strategies that researchers are
following with the intent of developing biocompatible polymer
coatings for IONPs as MRI contrast agents for stem cell tracking.
2 Synthesis of polymer coated IONPs
The experimental conditions used for the synthesis of IONPs
dictate the physical properties of the iron oxide core. The two
main techniques for synthesis of IONPs are co-precipitation and
thermal decomposition. Other less frequently used methods
include pyrolysis, hydrothermal reactions and sol–gel synthesis.
The volume of literature is vast in terms of synthetic procedures
for manufacturing iron oxide cores with the desired shape, size
and magnetic properties. For use in biomedical applications,
particles need to be stable in water and there are various routes
that have been followed using polymers to achieve colloidal
stability.
Co-precipitation is a simple technique for producing IONPs
by controlled precipitation of iron oxides using stoichiometric
amounts of aqueous Fe2+ and Fe3+ salts in the presence of
stabilising agents by addition of an alkaline solution in a non-
oxidising environment (eqn (1)), to form magnetite (Fe3O4).
Magnetite can transform into maghemite (g-Fe2O3) through
various electron or ion transfers depending on the pH and
oxygen content of the suspension used for co-precipitation (for
example, eqn (2)).8
Fe2+ + 2Fe3+ + 8OH- Fe3O4 + 4H2O (1)
Fe3O4 + 2H
+- g-Fe2O3 + Fe
2+ + H2O (2)
An advantage of this technique is the facile synthesis and
the large quantities of IONPs that can be produced. However,
the IONPs obtained are normally of a polydisperse nature.
A high degree of control over the particle size, magnetic properties,
and colloidal stability can be achieved by altering precursor salt
concentration, stabilising agent, reaction time and pH.4
Thermal decomposition oﬀers the advantage of producing
nanoparticles with a controllable narrow size distribution and
crystallinity, which is achieved by altering the ratios of reagents
used. The precursors undergo thermal decomposition in high
boiling point organic solvents containing surfactants. Examples
of iron complexes used for thermal decomposition are: iron
oleate, Fe(CO)5 and Fe(acac)3. However to be used for stem cell
labelling, the synthesised IONPs need to be transferred to water.
In terms of the magnetic properties obtained, there is no over-
riding advantage for using either co-precipitation or thermal
decomposition procedure. For stem cell labelling, many research
groups prefer to use the co-precipitation procedure with a poly-
mer stabiliser, which can render the particles hydrophilic, since
this is a one step process that can produce significant quantities
of IONPs. This procedure is also the most cost eﬀective; if
IONPs are to be used for clinical/commercial application, scale-up
of reactions would be easier in a water based system, avoiding
the use of high boiling point solvents and possible post-
modification steps.
In general, IONPs containing Fe3O4 cores are most widely
investigated due to their easier synthesis. It is thought that the
breakdown of Fe3O4 to g-Fe2O3 can cause toxicity issues in stem
cells,9 which could explain why some researchers prefer to pre-
oxidise particles prior to labelling.10 Even though it is thought
that g-Fe2O3 is more chemically stable and could be less toxic to
stem cells, comparisons between the two phases have not been
studied in great detail. This could come from diﬃculties in
synthesising stoichiometrically pure phases, as most synthe-
sised IONPs normally consist of a mixture of phases.
In addition, even though Fe3O4 has slightly higher saturation
magnetisation compared to g-Fe2O3, it is unlikely to increase MRI
contrast, for a recent study has shown that particles with very
diﬀerent magnetism generate similar relaxivities following uptake
into stem cells.11 For increased contrast, it is more important to
increase the mass of IONPs internalised.11
Hydrophilic polymer coatings give colloidal stability through
electrostatic or steric repulsion. The nature of the coating will
dictate the nanoparticle’s interaction with the cells during
labelling as well as their fate once localised to the intracellular
environment. A wide range of ‘‘biocompatible’’ polymers and
polysaccharides have been investigated as IONP coatings.
The development of living radical polymerization techni-
ques such as atom-transfer radical-polymerization (ATRP) and
reversible addition–fragmentation chain-transfer polymerization
(RAFT) has expanded the number of polymers that can be inves-
tigated, as well as the possible modes of attachment to the IONPs.
These techniques also allow the synthesis of statistical and multi-
block polymers with well-defined molecular weights and poly-
dispersity through control of the rate of propagation.
Some of the most common polymer modes of attachment
are shown in Fig. 3, along with modes of assembling polymers
around the iron oxide core. A number of potential modes of
attachment or interaction are possible: (a) attachment through
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a polymer end group directly attached to the iron oxide; (b) the
polymer is grafted or ‘‘clicked’’ on to pre-synthesised IONPs;
(c) a diblock copolymer is used where one block consists of
grafting group only and binds to the iron oxide surface; (d) a
polymer contains grafting groups throughout and is wrapped
around the iron oxide core; (e) electrostatic interactions between
coatings with opposite charges, where either one or both of the
electrostatic forces come from a polymer; (f) a micelle approach
using an amphiphilic polymer containing hydrophilic and
hydrophobic sections, where multiple hydrophobic iron oxide
cores are stabilised through hydrophobic interactions thus
making them stable in water.
The most favoured route for stabilisation of IONPs is perhaps
direct attachment to the Fe–OH group on the surface of the
precipitating nanoparticles. A permanent covalent attachment to
particles will be more likely to lead to long-term colloidal
stability. Some of the most commonly used functional groups
are shown in Fig. 4, where a reactive group that has an affinity
for Fe–OH is required.12 For example, small alkoxysilane mole-
cules can coat IONPs via attachment to the surface of the IONPs
with a silanol group forming a Fe–O–Si bond.3 It is commonly
stated that the bond formed between siloxanes and IONPs
is covalent, but this is still debated.13 Alkoxysilanes are versatile
as they can introduce various reactive groups to the IONP
surface that can undergo coupling reactions for specific appli-
cations. Some of the functional groups that can be introduced
are: amine, carboxylic acid, vinyl, and thiol.13,14 Attachment of
silica-based stabilisers can sometimes result in loss of colloidal
stability in water. In some cases, the coatings can be rendered
hydrophilic through a reaction with a polymer before or after
covalent attachment to the iron oxide core. If this is carried
out before grafting to the iron oxide, there is risk of self-
condensation reaction of siloxanes, so polymer grafting is
normally done after binding the alkoxysilane to the iron oxide.
Transfer from the organic solvent to the aqueous phase would
be required at some stage and this can be difficult to do effectively.
Phosphonic acids have a high affinity for Fe–OH, forming
Fe–O–P bonds and these have been shown to be more stable than
the corresponding Fe–OH carboxylic acid bond.12 Phosphonic
acid grafting groups have also been shown to lead to a higher
grafting densities compared with carboxylic acid and glycerol
containing polymers.15 COOH co-ordination is labile and can
easily be removed by temperature or by ligand exchange with a
group that has a higher affinity for Fe–OH, such as alkoxysilanes
Fig. 3 Various polymer-iron oxide stabilization methods (a) attachment comes from a functional group at the end of the polymer (b) the polymer is
grafted from or clicked on to a pre-synthesised IONPs (c) a diblock copolymer with one block consisting of grafting groups (d) a polymer contains
grafting groups throughout the whole polymer and adopts a wrapping conformation (e) electrostatic between coatings with opposite charges (f) an
amphiphilic polymer is used to stabilise hydrophobic IONPs in water.
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and phosphonic acid.12 Catechol containing reagents such as
dopamine are known to have good affinity to IONPs, but can
undergo redox transformations resulting in dissociation from
the surface of IONPs and loss of colloidal stability. This has
led to questions over the use of such chemicals in biological
applications.12
Polysaccharides are attached to IONPs via bonding between
OH groups contained throughout the polymer and the Fe–OH
on the surface of IONPs. This can occur in situ whilst the IONPs
are forming or in a post-modification step, with the polymer
wrapping around the IONPs as shown in Fig. 3d.
3 Labelling stem cells with IONPs
When labelling stem cells with polymer coated IONPs, there are
various safety aspects that must be taken into account, as
toxicity can arise from both the nature of the polymer coating
and the iron oxide core, as well as the labelling conditions used.9,16
Widespread use of IONPs in the clinic in the form of contrast
agents, coupled with key studies that were conducted in the early
1980s suggesting that molecular iron was of very low toxicity, led to
the general assumption that IONPs are biocompatible. However,
the data presented in the literature are sometimes conflicting,
with groups working on the development of IONPs often
purporting the safety of their formulations, whereas a smaller,
but increasing, number of independent studies report specific
toxicities.17 The use of IONPs as a contrast agent for organ
imaging diﬀers from its use for stem cell labelling. The former
involves the direct intravenous administration of a solution of
IONPs, whilst the latter implicates the labelling of cells in vitro,
which are then administered to the patient and/or animal model.
This has a consequence in how toxicity is perceived and assessed.
On the one hand, the mass of iron that is administered in each
case is very distinct. The recommended dose of Resovists and
Endoremt (the previously commercially available and approved
IONPs) was 0.80 or 0.56 mg of iron per kg of bodyweight,
respectively, with a typical 70 kg patient receiving an infusion
of 39 to 56 mg of iron. Labelled stem cells, on the other hand,
usually present intracellular iron concentrations in the range of
3 to 30 pg per cell. If bone marrow transplantation is taken as an
example, where about 3  106 haematopoietic (CD34+) stem cells
are injected per kg of bodyweight, the same patient would receive
2.1  108 cells or a total of 4.2 mg of iron if cells are loaded with
20 pg of IONPs each, which is approximately 10-fold less than an
intravenously administered dose. Although the relative dose is
smaller, reducing the chances of systemic toxicity, the target cells
are diﬀerent and require a careful assessment of the impact of
IONP labelling on their function. Unlike the macrophages of the
reticulo-endothelial system (RES, the target cells of Resovists and
Endoremt) stem cells are not professional phagocytes and might
be more sensitive to the high intracellular concentrations of iron
that are required for adequate contrast.
Stem cell tracking will usually be correlated with an assess-
ment of therapeutic potential, so perturbations in cell health
must be kept to a minimum to ensure that the cells can
perform their expected functions, which might include migra-
tion to the site of injury, integration and diﬀerentiation at the
target tissue as well as the production and release of small bio-
active molecules such as cytokines, chemokines and other
proteins that may aid tissue regeneration. In order to fully
assess the safety of IONPs, the physicochemical properties of
these nanomaterials must be thoroughly evaluated and specific
measures of dose defined. Once these aspects have been deter-
mined and quantified, they can then be correlated with any eﬀects
on cell health.
3.1 Dose and its relation with physicochemical properties
The response of a cell when treated with a compound is usually
expressed as a function of dose, usually in an eﬀort to establish
a dose–response relationship. When IONPs are taken into
consideration, the expression of dose is a difficult issue as no
agreement exists on the most appropriate approach, and most
investigators utilise the so called gravimetric doses.18 Here, the
most common example is the use of mass per volume of culture
medium (mg ml1). What must be taken into account, however,
is that this measure is not always the most relevant, particularly
when cell labelling is considered. Dose can be expressed at
various levels of specificity as shown in Fig. 5 and the nominal
media mass, surface area or number concentrations are all
non-specific and better defined as exposure.19 This is because a
cellular response will only take place when nanomaterials come
into contact with the cells (delivered dose) or are subsequently
internalised by them (cellular dose); a cellular response will not
occur when the materials remain suspended in the medium
Fig. 4 Functional groups that can react with the surface hydroxyl groups on a precipitated iron oxide nanoparticle: phosphonic acid, carboxylic acid,
catechol, hydroxyl, amine, glycerol and siloxanes.
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over the course of the experiment. Depending on the physico-
chemical characteristics of the IONPs, these measures of dose
can be very different, which is in contrast to soluble chemicals
where it is assumed that the nominal media concentration is
proportional to the cellular dose. As IONPs can only be used as
contrast agents for cell tracking if they are internalised by cells,
the cellular dose is most relevant for their evaluation. Thus, it is
imperative to provide this information when performing a
comparative assessment of different polymer shells for MRI
tracking. A ‘‘stealthy’’ PEGylated IONP, for example, that is not
readily internalised into stem cells might have a more favourable
toxicity profile in relation to other shells when the exposure dose
is considered. However, if such a stealthy shell prevents cellular
uptake, the favourable lack of toxicity will come at the expense of
(1) not being fit for the proposed applications and (2) the actual
inexistence of a cellular dose that prevents a direct comparison
with IONPs that are actually internalised by cells.
It is well known that IONP properties such as size, shape,
surface charge and functional groups can impact uptake and
thus, the cellular dose. Assessment of early toxicological studies
was often hampered by the lack of data related to these pro-
perties but it is now widely accepted that any reports on the
toxicological evaluation of nanoparticles must be accompanied
with this information. For polymer-coated IONPs, further infor-
mation such as the core size, crystalline structure and the
magnetisation of the material are all properties that should
be reported. It is important to note that particle size and zeta
potential can be dramatically aﬀected once IONPs are exposed
to cell culturemedium, which typically contains foetal calf serum.
Proteins in the serum adsorb to the surface of the IONPs,
aﬀecting their size and charge. It is therefore important that
the size and zeta potential of the IONPs are assessed following
incubation in cell culture medium. The strength of the grafting
bond plays an important role as competitive interactions between
polymers and proteins, as well as incubation temperature, could
result in the polymer being detached from the IONP surface,
which could have further implications on colloidal stability,
toxicity and observedMRI signal over time. Cationic shells appear
to generally facilitate delivery of IONPs to cells. The eﬀect of
particle size is less clear, with some studies suggesting an
optimal size around 50 nm for uptake, although the notion of an
‘‘optimal’’ size has been challenged by some research groups.20
What should always be monitored, however, is the colloidal
stability of the IONPs. Studies have shown that the use of
transfection agents can aﬀect particle size with the generation
of particle aggregates.2 In such cases, gravitational settling might
become a dominant force aﬀecting the delivery dose, that is, the
amount of IONPs that reach and interact with the cell membrane.
This is undesirable as it can lead to a substantial deposition of
IONPs over the cells and the formation of extracellular aggregates
that can be very diﬃcult to wash away.
3.2 Labelling and evaluation
Labelling of stem cells is usually achieved by simply co-culturing
the cells of interest with IONPs. Diﬀerent endocytic mechanisms
have been suggested to be involved in IONP internalisation by
cells, but there is no clear established relationship between
physicochemical properties and specific mechanisms of uptake.
Cationic polymer shells appear to facilitate IONP internalisation,
which is thought to be related to electrostatic interactions with the
negatively charged cell membrane surface thus promoting adsorp-
tive endocytosis. Dextran based shells, which are neutral, usually
present low uptake2,21 and require modifications for eﬃcient
cellular internalisation. That usually involves small molecules
such as transfection agents2 but can also be achieved by direct
modification of the polymer shell by adding amine function-
alities. We will discuss diﬀerent polymer systems and levels of
uptake that are achieved in stem cells in the following sections.
For polymer shells that lead to poor cell internalisation, physical
methods such as electroporation, microinjection and ‘‘magneto-
fection’’, where IONP-cell contacts are manipulated using
magnetic fields, have also been previously reported.2,22 Avoiding
the need to use such methods, however, is one the goals when
designing new polymer shells and thus these will not be dis-
cussed in detail here.
When evaluating new IONPs for stem cell labelling, it is
important to correlate the exposure dose with the cellular dose.
(i.e. uptake). As it was previously mentioned, the cellular dose is
the measure of most relevance when stem cell tracking is con-
sidered, and the one that should be considered when assessing
diﬀerent IONPs designs. A comparison of the toxicity profile and
imaging properties of IONP-labelled cells is most accurately
assessed when the cellular dose is used as a reference, as opposed
to the commonly employed exposure dose.
Fig. 5 Diﬀerent levels of specificity can be used when defining dose.
Exposure dose is the nominal mass (or number) of IONPs in the culture
medium. The delivered (or deposited) dose is the mass (or number) of
particles that actually get in contact and interact with the cells. The most
specific measure and the one of relevance for cell tracking is the cellular
dose, which corresponds to the mass (or number) of particles that are
taken up by the cells and that will be responsible for generating contrast
in vivo.
Tutorial Review Chem Soc Rev
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
Ju
ly
 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
1/
09
/2
01
5 
13
:4
5:
08
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry 2015 Chem. Soc. Rev., 2015, 44, 6733--6748 | 6739
The cellular dose of IONPs can be determined by harvesting
the cells after the labelling period and then measuring the
amount of iron in the sample either by bulk quantification
methods, such as inductively coupled plasma atomic emission
spectroscopy (ICP-OES) and colourimetric assays or by more
refined methods such as cell tracking velocimetry (CTV), where
the speed of IONP labelled cells under a magnetic field can be
used to calculate the amount of internalised iron. As previously
reviewed,2 most of these techniques can provide an accurate
quantification of iron, although care must be taken to ensure the
cellular dose is not overestimated by the carryover of extracellular
(not internalised) aggregates, an issue which is of particular
significance when using nanoparticles that are not colloidally
stable. Cellular dose is commonly expressed in terms of the mean
mass of iron per cell and is generally in the range of 3–30 pg[Fe]
per cell. The cellular doses that can be achieved will not only
depend on the labelling conditions (exposure dose and time) and
the physicochemical characteristics of the IONPs in the relevant
culture medium but also with the origin and function of the cells
being evaluated and their respective endocytic capacity.
The uniformity of the cellular dose within the population is
another important parameter that requires assessment and that
is usually reported as ‘‘labelling eﬃciency’’. We have previously
shown by CTV that even for homogenous cell lines, the cellular
dose on a cell-to-cell basis can show great variability, even when
all the cells in a population are labelled.21 Labelling eﬃciency
can be qualitatively assessed by image analysis of Prussian blue
stained cells, non-invasive imaging techniques such as photo-
thermal microscopy,23 or if a fluorophore is present in the shell,
via flow cytometry.11 Although one is likely to find small cell-to-
cell variations in IONP content, it is important to ensure that
that the labelling is suﬃciently uniform within the population of
interest. This is particularly important when working with
heterogeneous cell populations, where the labelling eﬃciency
between the two or more cell types present in the sample might
be diﬀerent.
If the labelling eﬃciency is adequate, the cellular dose can
then be used has a reference when evaluating the detection
limits via MRI, bearing in mind that relaxivity can undergo
significant changes when IONPs are internalised in cells.11
Furthermore, in vitro studies focussing on possible eﬀects on
cell health can then be carried out to evaluate not only general
markers of toxicity but also the specific functions of the target
cell. Absence of cell death following labelling is an obvious
requirement. However, this is not enough and the assessment
of stem cell health should include investigations on prolifera-
tion and migration capacity, the preservation of specific surface
markers, diﬀerentiation potential (‘‘potency’’) and functionality
of the stem cell and its derivatives as well as whether the labelled
cells can induce any immunogenic response. Cell morphology
and cytoskeleton integrity can also provide further information
on cell health.17,24 Potency will be stem cell specific and func-
tionality will be correlated to the functions expected from the
stem cell or its derivatives. For example, for cells whose function
are secretory, this will be defined as the release of hormone and
growth factors, whereas in the case of mechanically active cells
such as diﬀerentiated cardiomyocytes this will be expressed as
electric and mechanical activity.25 Stem cells used for therapies
in the brain should be evaluated with particular attention, as the
central nervous system appears to be exceptionally susceptible to
transition metals and oxidative stress17 and one should not only
evaluate the health of the stem cells but also that of neigh-
bouring cells such as microglia, which can become activated if
exposed to IONPs. A range of assays to evaluate diverse aspects
of cell health such as the cell’s metabolic activity, the presence of
free radicals and the extent of cell death (if any) are commercially
available. However, it is worth noting that sometimes IONPs can
interfere with the readout of an assay (such as absorbance,
luminescence of fluorescence) and proper controls must be used
to avoid misinterpretation.24,26
3.3 Potential mechanisms of toxicity
Once internalised, IONPs are usually traﬃcked to the lyso-
somes2,11 where they stay in the long-term unless mechanisms
such as starvation stress result in their release, via extracellular
vesicles, in the cell culture medium.27 The presence of large
numbers of nanoparticles intracellularly is thought to be a
possible cause of cell toxicity. A cell labelled with 10 pg of IONPs
with a core of 8 nm, for example, would contain over 10 million
nanoparticles with a potentially highly reactive surface area.
Additionally, it is well accepted that the acidic environment
(pH B 4.5) of the lysosomes might result in at least partial
dissolution of IONPs with time,6,28 resulting in iron ions being
leached from the particles. These two factors (surface area and
leaching of iron ions) are thought to be the main mediators of
intracellular toxicity through the generation of reactive oxygen
species (ROS). The degradation of IONPs can be quantified
using citrate containing buﬀers at pH 4.5. Although it does not
exactly mimic a lysosomal environment, this can be a useful
tool for comparing the stability of diﬀerent iron oxide cores.2
For example, the use of small molecules such as citrate28 and
2,3-dimercaptosuccinic acid29 as coatings appear to lead to a
lower stability when compared to the use of polymers. In the
case of the former, Soenen et al. compared the acidic stability of
the iron oxide core of Endoremt and Resovists (both dextran
based coatings) with citrate coated very small organic particles
(VSOPs) at various pH.28 At pH 4.5 they found that the release of
ferric irons was much higher which led to a loss in MRI contrast,
whereas Endoremt still exhibited MRI contrast after 2 weeks.
The lack of iron oxide stability of VSOPs was accompanied by
a loss of viability and increase in ROS when labelling neural
progenitor cells, which was not seen with the dextran based
particles. The authors, however, stress that whilst coating does
play a major role in the stability of the iron oxide core, this is not
the only governing factor. Factors such as core size, core com-
position, hydrodynamic diameter and the overall available sur-
face area are also likely to contribute to stability in a lysosomal
environment.
Cells are constantly generating reactive oxygen species (ROS),30,31
with mitochondria producing superoxide (O2
) and hydrogen
peroxide (H2O2) species.
31 Iron, however, is involved in the
generation of the extremely reactive hydroxyl radical (OH) via
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Harber–Weiss type reactions (eqn (3)). This occurs via a
reduction of ferric iron to ferrous iron (eqn (4)), followed by
Fenton chemistry (eqn (5)).31 As such, the formation of these
radicals can be catalysed at the surface of the IONPs, or via free
iron ions released in the cell’s cytoplasm. Although hydroxyl
radicals have a very short half-life (nanoseconds) and a short
radius of action (o10 Å),30,31 they can cause extreme damage to
molecules in their vicinity.
O2 þH2O2!
Fe2þ=Fe3þ
OHþOH þO2 (3)
Fe3+ + O2
- Fe2+ + O2 (4)
Fe2+ + H2O2- Fe
3+ + OH + OH (5)
Mammalian cells have protective mechanisms against free
radicals but it is the imbalance between pro-oxidant and anti-
oxidant factors that can lead to potential damage. Increased
production of ROS can result in the oxidation of protein, nucleic
acids as well as lipids. Oxidised proteins tend to denature,
making them more susceptible to proteolysis. The oxidation of
DNA bases, on the other hand, can have more serious con-
sequences. Although this sort of damage always exists at a basal
level and repair systems are in place within the cell to remove
such defects, if damage occurs at critical sites that cannot be
quickly repaired, it can lead to genetic mutations that can play
a role in carcinogenesis. In lipids, hydroxyl attack of the double
bonds that exist in polyunsaturated fatty acids yields a new
radical that can, in turn, abstract a second electron from another
fatty acid leading to a chain reaction aﬀecting lipid bilayers,
membrane transport and ion channels.31 All these eﬀects can
interfere with signal transduction pathways directly or indirectly,
promoting cell stress. The response to IONP degradation and
related stress will be cell specific, and in some cases, the presence
of free iron may even promote cell proliferation, as recently
reported for human mesenchymal stem cells (hMSCs).32 In
general, however, a small and transient elevation in ROS can be
tolerated, but persistent higher levels will lead to cell damage.24
Some recent studies have shown that medium supplementation
with iron chelating agents such as deferoxamine can reduce toxic
eﬀects in mesenchymal stem cells33 and that the use of anti-
oxidants can reduce toxicity of IONPs to hepatocytes,34 thus
indicating that the presence of iron ions and oxidative stress
are two important triggers of toxicity.
4. Polymer design or selection for
stem cell labelling
A wide range of hydrophilic polymers have been investigated as
coatings for IONPs but not all of them lead to internalisation
into stem cells. The surface properties of IONPs and other
nanoparticles are argued to be critical for the interactions they
have with the surrounding physiological media and the path
they follow in vitro and in vivo.35 For example, there has been a
focus on the production of IONPs with polycationic and poly-
anionic shells as they can lead to considerable uptake into
stem cells. A common theme is to compare novel materials
against the two formerly clinically approved products, Endoremt
or Resovists, in one particular stem cell line, although uptake
values can be subject of large errors depending on the labelling
procedure and quantification method used. As mentioned
earlier, whilst the formerly clinically approved products have
been used extensively to label stem cells, they were designed as
liver-specific MRI contrast agents. For high levels of stem-cell
uptake, these two products require the use of a transfection
agent. A list of polymer coated IONPs for stem cell tracking will
be discussed in the following sections. The structures of some
of these polymers are shown in Scheme 1 along with tabulated
results (Table 1) which gives information on their mode of
assembly and reported uptakes into specific stem cell lines. In
some cases, if the hydrophilic polymer shell does not lead to
uptake, the particles will be functionalised with a chemical that
alters the surface charge and/or alter the protein binding ability
in cell culture medium.8 Some researchers also prefer to attach
specific cell penetrating peptides to the polymer shell, but this
can be expensive and uptake can be generated through other
cost-eﬀective means, which we will discuss in the following
sections.
4.1 Polysaccharides
Polysaccharides derived from living systems are widely used as
coatings for IONPs. They are generally highly water-soluble,
biodegradable and inexpensive. Dextran is synthesised from
sucrose by certain lactic acid bacteria and is one of the most
commonly used polysaccharides; it is also FDA approved as a
blood-thinning agent. In fact, the first co-precipitation of IONPs
utilised dextran.36 Chitosan is another polysaccharide polymer
used for coating IONPs. It consists of statistical amounts of
b-(1-4)-linked D-glucosamine and N-acetyl D-glucosamine as a
result of the deacetylation synthesis from chitin, found on the
exoskeleton of crustaceans. Like dextran, chitosan is highly
soluble and biocompatible. Due to the amine groups on the
polymer, chitosan carries a slight positive charge at physio-
logical pH. Reddy et al. demonstrated eﬃcient labelling of hMSCs
with commercially available Resovists (carboxy-dextran coated)
and chitosan coated IONPs with the aid of the transfection agent
poly-L-lysine (PLL).37 The uptake of both sets of particles were very
similar (around 18 pg[Fe] per cell) and neither aﬀected viability,
proliferation, surface marker expression and adipogenic and
osteogenic diﬀerentiation potential. Whilst the chitosan particles
did not aﬀect the chondrogenic potential of hMSC, Resovist did,
although it is not clear if this was due to the IONP coating or the
iron oxide core.
Carboxymethyl functionalised chitosan (CMC) has been inves-
tigated as a coating without the use of a transfection agent.38 It
was found that conjugation to a pre-formed (3-aminopropyl)-
trimethoxysilane (APTMS) was a more eﬃcient method for
suﬃciently coating IONPs with polymer when compared to
methods that did not include APTMS. This was achieved first
by deacetylation of chitosan, followed by the introduction of
a carboxymethyl groups which could be covalently bound to
aminosilane coated IONPs using 1-ethyl-3-(3-dimethylaminopropyl)
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carbodiimide (EDC)-/sulfo N-hydoxysuccinimide (NHS) coupling
chemistry, a widely used technique for covalent linking of
primary amine and carboxylic acid groups (Scheme 2). This led
to twice the coverage of polymer using CMC and APTMS instead
of CMC alone, which made the surface charge more negative
(14 mV vs. 21 mV) owing to the presence of more carboxy-
methyl groups in the IONP shell. The uptake of CMC-IONPS and
CMC-APTMS IONPs into hMSC was compared and the CMC
APTMS particles where shown to be internalized significantly
more, which was confirmed by Prussian blue staining and ICP-
MS, with the maximum uptake measured at 26 pg[Fe] per cell
using an exposure concentration of 50 mg ml1 of iron and
24 hours incubation time. Such uptakes did not cause signifi-
cant cytotoxicity, nor interfere with osteogenic and apipogenic
diﬀerentiation of hMSCs.38 The limit of detection was sug-
gested to be around 40 cells in an agarose phantom as MRIs of
labelled hMSCs exhibited significant negative contrast.
Our research group synthesised a series of dextran-based
IONPs with surface charges ranging from 1.5 mV to +18.2 mV
using commercially available 40 kDa dextran polymers in a
co-precipitation approach. We demonstrated that manipulating
the surface charge by varying the amine containing DEAE-
dextran within the polymer coating can give a degree of control
over stem cell uptake. First, the library of particles was shown to
be colloidally stable in cell culture medium for 14 days, which
far exceeded the 24 hour labelling period. It was important to
show that the diﬀerences in surface charge were responsible for
increased uptake rather than sedimentation of particles. The
most positively charged IONPs provided a 6-fold uptake in
mouse MSCs (mMSCs) up to 3.8 pg[Fe] per cell with respect
to neutral dextran coated particles (Fig. 6a) and this trend in
uptake was also observed in human and mouse kidney-derived
stem cells. Interestingly, we also showed that magnetophoretic
mobility of cells (Fig. 6b) could be used as an accurate proxy for
predicting the resultant MRI contrast of stem cells after labelling,
as it is sensitive to both uptake and magnetisation of individual
cells (Fig. 6c and d).21
Pullulan, containing maltotriose units, has been investi-
gated as a coating for IONPs. One particular study focused on
creating pullulan coated IONPs with diﬀerent surface charges
and sizes and evaluating the eﬀect this could have on the uptake
into bone marrow-derived rat mesenchymal stem cells (rMSCs).39
To vary surface charge, pullulan was functionalised with ethylene-
diamine to give the polymer a positive charge, and succinic
anhydride was introduced to give a negative charge to the
polymer. The size of the IONPs was altered through manipula-
tion of the polymer to iron salt ratios. This study evaluated inter-
nalization of IONPs with charges ranging from 10 to +12 mV
and determined that uptake was lower as the surface charge
became more negative; as the charge increases and becomes
more positive, the uptake increased. Pullulan alone was not an
eﬀective coating for internalization of IONPs. Also, when particles
in the range of 69 to 161 nmwere compared, uptake was shown to
be higher when the IONPs had lower hydrodynamic diameters,
Scheme 1 Polymers commonly used as coatings for IONPs.
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up to a maximum uptake of 65 pg[Fe] per cell. All of the uptakes
were reflected in the observed shortening of T2 relaxation times
of labeled rMSCs suspended in a gel phantom. Again, these
labeling procedures were shown to not aﬀect viability or the
diﬀerentiation potential of the cells.39
Most polysaccharide polymers bind to IONPs through the
OH functionality contained in each sugar unit on the polymer
‘‘wrapping’’ around the nanoparticle (Fig. 3d and 4). An impor-
tant issue with these coatings is that heat treatment can cause
the polymer to dissociate from the iron oxide. If the polymer is
removed from the surface of IONPs, this could have implica-
tions on the long term colloidal stability as well as the resis-
tance of the iron oxide core against the slightly acidic lysosomal
compartment. Researchers have been able to work around this
problem via crosslinking the polysaccharide chains through
crosslinkers such as epichlorohydrin for dextran and glutalde-
hyde for chitosan.
4.2 Functionalisation of ‘‘stealthy’’ polymers
Polyethylene glycol (PEG) derivatives are commonly used as a
coating for IONPs due to their hydrophilicity and biocompati-
bility. It is regarded as a ‘‘stealthy’’ coating due to low uptake of
PEG coated materials into most cell types and long circulation
time in the blood. However, PEG polymers can be function-
alised with certain groups that can lead to stem cell uptake
whilst maintaining biocompatibility.
An easy method for preparing PEG coated IONPs through
organic to aqueous phase transfer has been reported.40 A library
of PEG based polymers were screened for this purpose with
functionalities such as OH, SH, COOH and NH2 with diﬀerent
molecular weights and structures. A six-armed PEG-NH2 (15 kDa)
derivative was found to be the best polymer system for trans-
ferring oleic acid IONPs from chloroform to water, which could
be measured by the amount of scattering observed in the
resultant solutions by ultraviolet visible spectroscopy (Fig. 7).
The PEG-NH2 derivative led to uptakes of around 0.6 pg[Fe] per
cell in hMSCs, but this could be further improved by EDC/NHS
coupling to hyaluronic acid, a biofunctional polymer, to obtain
uptake of 1.5 pg[Fe] per cell. The conjugation of hyaluronic acid
was confirmed by Fourier transform infrared spectroscopy and
zeta potential measurements, as the surface charge went from
+12.8 mV (before conjugation) to 9.1 mV (after conjugation).
It is suggested that the presence of hyaluronic acid could increase
the amount of cell surface glycoprotein CD-44 mediated endo-
cytosis40 This strategy is therefore a targeted delivery method,
unlike the previously discussed shells that rely on unspecific
interactions with the cell’s surface for uptake. In such cases the
strong aﬃnity of the shell with cell surface receptors is likely to
be of more relevance than specific properties of the IONP shell
such as the zeta potential.
The usual strategy for binding PEG based polymers is through
the use of functional grafting groups at the end of the polymer
(Fig. 3a). However, more grafting groups can be added to
polymers through living radical polymerisation methods. For
example, the versatility of RAFT was demonstrated by synthe-
sising three PEG based block co-polymers with diﬀerent graft-
ing groups: phosphonic acid, carboxylic acid and glycerol
(Fig. 3c and 4).15 The three polymers were used to synthesise
SPIONs in a co-precipitation approach using various polymer
to iron salt ratios whilst keeping the concentration of the
iron salts the same for every reaction. This allowed for direct
Scheme 2 Covalent conjugation of carboxylic acid functional particles
with primary amines. An EDC intermediate is formed, before formation of a
sulfo-NHS ester which reacts with a primary amine.
Fig. 6 (a) Intracellular iron content of cells labelled for 24 h with 50 mg ml1
[Fe]. Error bars correspond to the SD from three independent measure-
ments. (b) The magnetic velocity of cells labelled for 24 h with 50 mg ml1
[Fe]. Data was acquired from a minimum of 100 cells for each condition.
Horizontal (red) bars indicate the mean magnetic velocity of the population.
(c) 7 T MR scan of 3  105 MSCs suspended in a 40 ml agarose phantom,
after 24 h labelling with 50 mg ml1 [Fe] of each SPION (images as obtained
with a RARE sequence). (d) Relaxation times of the region of interest contain-
ing the cells. Error bars represent the standard deviation. Figure reworked from
reference with permission.21
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comparison of grafting groups and the eﬀect they can have on
the synthesised IONPs.
Phosphonic acid groups were shown to have the highest
grafting density followed by carboxylic acid and the glycerol
derivative. For all of the functional groups, some control over the
core size and relaxivity could be obtained through manipulation
of the polymer to iron salt ratio used for IONP synthesis. In
general, the core size and relaxivity could be increased through
decreasing the amount of polymer in the IONP synthesis; how-
ever, this can also have a detrimental eﬀect on colloidal stability
(Fig. 8). Through selection of the chain transfer agent used for the
RAFT polymerisation, all polymers contained an alkyne group,
which could potentially be used to attach or ‘click’ specific func-
tional groups to the particles to increase uptake into stem cells.15
4.3 Other charged polymers
Polymers bearing a positive charge are widely used to deliver
material into cells including IONPs.41 Generation of positive
charges on polymer coated IONPs generally comes from polymers
or molecules containing amine groups (primary, secondary or
tertiary). When the polymers are in an aqueous environment and
the pH of the solution is below the pKa of the amine functional
group, the amine will become protonated giving it an overall
positive charge. Polymers or molecules containing carboxylic acid
groups can be used to generate a negative charge.
PLL has been used extensively both as a transfection agent for
IONPs but also as a coating itself.37,42,43 PLL was investigated as
a coating for g-Fe2O3 IONPs at various molecular weights ranging
from 146 Da (L-lysine) to PLL polymers up to 579 kDa and
compared with Endoremt using rMSCs and hMSCs.43 The PLL
coating was incorporated into already synthesized citrate coated
particles through electrostatic interactions (Fig. 3e). The percentage
of labelled rMSCs was highest when using PLL with a molecular
weight of 388100 Da, and was considerably higher than that of
Endorem in both rMSCs and hMSCs, although uptake values
were not quoted. This was indeed verified when 1000 rMSC
cells labelled with PLL and Endoremt were implanted into the
left and right hemisphere of a rat brain respectively (Fig. 9).
A clear diﬀerence in negative contrast can be observed, with PLL
labelled cells showing more darkening than Endoremt labelled
cells due to the greater internalisation of IONPs. In addition, the
viability of PLL coated particles was shown to be much higher
than that of Endoremt.43
Whilst in this study an excess of PLL was left after conjugation
with the IONPs, Ju et al. demonstrated that extra washing pro-
cedures can be used to wash away any ‘‘free’’ PLL not associated
with IONPs, thus lowering the overall PLL to iron oxide ratio,
whilst maintaining ‘‘safe’’ uptake into human umbilical MSCs of
up to 65 pg[Fe] per cell.42
Fig. 7 Structure of the functionalised PEG library used for phase transfer
of oleic acid coated IONPs into aqueous conditions and a bar chart
showing the absorbance of the aqueous phase after transfer of IONPs
from chloroform to water. Figures reworked from ref with permission.40
Fig. 8 Images showing how core size, relaxivity and colloidal stability can
be tuned through selection of grafting group and polymer to iron salt ratio
used in co-precipitation reaction. Figure used from ref. 15.
Fig. 9 (a) Axial and (b) coronal MR images of a rat brain with 1000 cells
implanted into the left hemisphere labelled with PLL-coated IONPs and
1000 cells implanted into the right hemisphere labelled with Endoremt.
Taken from ref. 43 with permission.
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Other polycations that have been used as coatings include poly-
ethylenimine (PEI) and poly(N,N-dimethylacrylamide) (PDMAAm).
PEI is a polymer containing primary amines that has been
shown to have transfection eﬃciency at a molecular weight of
25 kDa. Like other transfection agents, PEI can also induce cell
death and inhibition of cell diﬀerentiation. Using relatively low
molecular weight PEI (2 kDa) has been shown to improve
biocompatibility. The low molecular weight PEI was reacted
with a hydrophobic alkyl chain, which allowed for stabilisation
of clusters of pre-formed hydrophobic IONPs in water. This
represents the micellar structure shown in Fig. 3f owing to the
amphiphilic nature of the polymers used to stabilise hydro-
phobic IONPs in water. After successful labelling of mMSCs, the
IONPs could be detected in vivo for at least 19 days after trans-
plantation using a clinical 3 T MRI scanner with uptakes of
7 pg[Fe] per cell at highest dose and incubation time (7 mg ml1
Fe for 24 hours).44 The hybrid polymer coated IONPs also had
no cytotoxic properties.44
PDMAAm coated g-Fe2O3 IONPs were prepared by co-
precipitation of iron salts to form magnetite and oxidised using
sodium hyperchlorite to produce ‘‘bare’’ maghemite particles.
The particles were then coated with PDMAAm by polymerising
(N,N-dimethylacrylamide) in the presence of bare maghemite
particles using free radical polymerisation. The particles
were compared to Endoremt with uptakes far greater, up to
36.9  0.5 pg[Fe] per cell in hMSC and 23.2  2.9 pg[Fe] per cell
in rMSC, with no change in viability for either.10
Poly(N,N-dimethylaminoethylmethacrylate) has been conjugated
to IONPs via ATRP using a ‘‘grafting from’’ approach (Fig. 3b). The
ATRP initiator was first used to stabilise IONPs using a solvothermal
synthesis method. Hydrophilic SPIONs could then be produced by
grafting the polymer from the surface of the pre-synthesised IONPs.
The molecular weight could be controlled through the ATRP
methodology to maximise both gene expression of cells and
lower cytotoxicity. The cationic nature of these particles (zeta
potential +50 mV before complexation) was used as magneto-
transfection agents for DNA. Even without an external magnetic
field, the IONPs still exhibited considerable uptake in human
embryonic kidney cells HEK 293T cells after just a 10–30 minute
incubation periods (up to 3 pg per cell). They also exhibited
a surface charge of around +50 mV before complexation with
DNA, which could further increase uptake into stem cells.45
4.4 Protein corona studies of polymer coated IONPs
It has been clearly been demonstrated that charge can aﬀect the
internalization of IONPs into various stem cell lines. However,
it is still not precisely clear if it is the polymer coating that leads
directly to uptake, or if it is the polymer and charge specific
proteins that are incorporated in the protein corona in cell
culture medium during labelling. Most studies suggest that it is
the protein corona formed around IONPs that cells ‘‘recognise’’
during labelling. In an eﬀort to understand more about how the
coating type aﬀects the fate of IONPs in living systems, there
are now more studies emerging focusing on the quantitative
analysis of the protein corona that forms around IONPs in cell
culture medium.
For labelling of stem cells, IONPs are required to be trans-
ferred into culture medium, which will contain salts and
proteins that are necessary for their growth and the mainte-
nance of their stem-like phenotype. It is well known that a
‘‘protein corona’’ forms that is specific to the nature and charge
of the polymer coating. While there are more studies emerging
focussing on the composition of the protein corona formed for
particular systems, the role of the corona in stem cell uptake
and resistance to physiological pH in an intra/extracellular is
not clearly understood. The previously mentioned citrate assay
method, which is used to measure the stability of IONPs in
physiological pH does not take the formation of a protein corona
into account.
Parak’s group has commented on the importance of char-
acterizing nanoparticles in the correct media along with the
need for more quantitative data regarding the protein corona
formed around IONPs. In their opinion, the three most impor-
tant technical challenges are (1) insuﬃcient quality of IONPs,
in terms of size distribution and agglomeration (2) lack of
precise data of nanoparticle concentrations and (3) purification
of nanoparticles once the protein corona is formed.35 They also
stress with the third point the diﬃculty of separating nano-
particles plus protein corona frommedia, as some of the weakly
bound proteins in the protein corona may dissociate during the
purification process.
Hofmann’s group46–49 have produced a series of research
papers based on PVA, PEI and dextran coated IONPs with
different surface charges and compared the adsorption of pro-
teins on to the surface in cell serum. These studies highlighted
the difficulty of predicting the structure of the protein corona, but
they have also demonstrated that the type and surface charge of
polymer coated IONPs play a dominant role in protein adsorp-
tion. This could affect both colloidal stability and toxicity. The
reason why there seems to be no observed correlation between
the net charge of adsorbed proteins and the surface properties
of the IONPs is likely due to the complexity of protein structure.
For instance, conformation, charge distribution and also the
hydrophilicity/hydrophobicity of the adsorbed proteins could
all affect the zeta potential measurement.
The role of surface charge of IONPs was again investigated
with respect to protein adsorption and cell uptake by comparing
poly(acrylic acid) coated IONPs (negatively charged) with PEI
coated IONPs (positively charged).50 To accurately determine the
eﬀect of surface charge on the size of the protein corona formed,
both sets of particles were designed to have a hydrodynamic
diameter of 30 nm. Once exposed to cell culture medium, the
hydrodynamic diameter was found to increase significantly, up to
100 times for PEI-coated and around 30 times for polyacrylic acid-
coated IONPs. Maximum uptake of PEI coated IONPs was nearly
double that of the PAA coated IONPs.50 This raises the question of
whether cell uptake is dependent on hydrodynamic diameter in
cell culture medium, as both sets of particles carried a negative
charge between 10 and 20 mV.
The protein corona formed around some polymer coated
IONPs are now better understood in vitro, but it is still not
clear if this reflects the protein corona that forms in vivo.
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Sakulkhu et al. showed that the composition of the ‘‘hard’’
protein corona (the proteins tightly adsorbed on the IONP
surface) can be quite diﬀerent in vitro and in vivo for positive,
negative and neutral PVA coated IONPs.47 Whilst this study did
not involve stem cell labelling, it highlights an important point
that the protein corona may diﬀer/change in the transition
from in vitro to in vivo and this may aﬀect the fate of IONPs,
depending on the polymer coating.
5 Conclusions and perspectives
In this tutorial review, we have covered aspects related to the
design and in vitro evaluation of novel polymer coated IONPs.
We hope that the recommendations described in this article
provide the essential information required to translate novel
materials to pre-clinical assessment, particularly when evaluat-
ing the therapeutic potential of stem cells with the use of IONPs
as a means to image them in vivo. Clinical translation, however,
involves a good understanding of the regulatory pathways that
although not covered here, can be assessed in a recent review of
the subject.51
The use of polymers as coatings for IONPs is well established
and there is now a wealth of literature demonstrating how
changing the nature and charge of the polymeric shell can
dictate the fate of IONPs in vitro and in vivo. The mass of IONPs
internalised seems to be the most important parameter for
determining the observed MRI contrast of labelled stem cells
as IONPs with diﬀerent sizes, mode of assembly and solution
relaxivity have already been shown to have very similar relaxivity
once internalised into stem cells.11 There is now significant of
evidence that cationic polymer coatings are the most eﬀective
for uptake of IONPs into stem cells and tailoring surface charge
can give a degree of control over uptake. Hydrophilic polymers
have shown to increase colloidal stability of IONPs, but the role
that the polymer shell can play in the integrity of the iron oxide
core and resultant toxicity needs to be explored further and
provides significant synthetic challenges. Ideally, one should
start with IONPs with very similar core size, core phase and
hydrodynamic diameter. This could allow comparisons for
example, between molecular weight and degree of crosslinking.
New emerging polymerisation technologies are increasing the
amount of polymers that can be used as IONP coatings as well
as the diﬀerent modes of attachment to IONPs. This review is
aimed at highlighting key considerations that must be made when
‘‘designing’’ polymer coated IONPs and these are summarised
in Fig. 10.
It is worth remembering that each type of polymer coated
IONP has unique physicochemical properties that are further
changed under labelling conditions. Each cell type is also unique,
and might respond in diﬀerent ways to the IONP labelling.
It is clear that a greater understanding of the physical pro-
perties of IONPs in culture medium is needed, along with the
cell labelling process itself to achieve the highest mass of IONP
uptake without compromising stem cell health and function.
As we have discussed here, the protein corona that forms
during labelling is influenced by both the charge and coating
of the IONP. However, although more studies are emerging to
quantify these proteins in detail, the overall role of the protein
corona in the fate of IONPs in biological systems e.g. uptake,
colloidal stability and toxicity is still not well understood and
remains to be determined.
Fig. 10 Key considerations and things that should be reported when designing polymer coated IONPs for stem cell tracking.
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In terms of MRI, it is important to remember there is also
the problem upon implantation of knowing whether one is
imaging implanted stem cells or host tissue, as there is evidence
suggesting that upon cell death contrast agents can be transferred
to host cells generating false positives. It is likely that true
stem cell tracking through MRI alone is not enough, and MRI
combined with another imaging modality such as biolumines-
cence is required to allow cell viability to be correlated with the
anatomical localisation of iron-oxide labelled stem cells as
observed via MRI.2,7,52
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